Characteristics | Cancer DBT | Cancer DM | FP DBT | FP DM | ||||
---|---|---|---|---|---|---|---|---|
Adjusted OR (95% CI) | p Value | Adjusted OR (95% CI) | p Value | Adjusted OR (95% CI) | p Value | Adjusted OR (95% CI) | p Value | |
PD 1 | 1—Reference | 1—Reference | 1—Reference | 1—Reference | ||||
PD 2 | 1.25 (0.68–2.27) | 0.48 | 1.21 (0.62–2.39) | 0.58 | 2.23 (1.43–3.48) | < 0.001 | 2.06 (1.22–3.47) | 0.007 |
PD 3 | 1.68 (0.95–2.98) | 0.08 | 1.80 (0.96–3.39) | 0.07 | 1.85 (1.85–4.39) | < 0.001 | 2.39 (1.43–3.97) | 0.001 |
PD 4 | 1.69 (0.94–3.05) | 0.08 | 1.62 (0.83–3.15) | 0.16 | 2.82 (1.83–4.35) | < 0.001 | 2.84 (1.72–4.68) | <0 .001 |
PD 5 | 2.56 (1.41–4.65) | 0.002 | 1.69 (0.82–3.50) | 0.16 | 3.67 (2.39–5.63) | <0 .001 | 3.06 (1.85–5.05) | < 0.001 |
Trend PD | 1.24 (1.09–1.42) | 0.001 | 1.15 (0.98–1.34) | 0.08 | 1.27 (1.17–1.38) | < 0.001 | 1.24 (1.13–1.37) | < 0.001 |
Postmenopausal | 3.04 (1.94–4.78) | < 0.001 | 2.71 (1.60–4.56) | < 0.001 | 0.63 (0.50–0.78) | < 0.001 | 0.66 (0.50–0.86) | 0.002 |
Previous Screening | 0.81 (0.42–1.56) | 0.52 | 1.34 (0.53–3.42) | .54 | 0.82 (0.62–1.09) | 0.17 | 0.82 (0.58–1.16) | 0.27 |
DA 1 | 1—Reference | 1—Reference | 1—Reference | 1—Reference | ||||
DA 2 | 1.37 (0.74–2.54) | 0.32 | 1.32 (0.69–2.50) | 0.40 | 1.17 (0.78–1.74) | 0.45 | 1.16 (0.73–1.83) | 0.53 |
DA 3 | 1.47 (0.85–2.90) | 0.15 | 1.24 (0.64–2.41) | 0.53 | 1.50 (1.03–2.19) | 0.03 | 1.28 (0.82–2.00) | 0.28 |
DA 4 | 2.43 (1.36–4.35) | 0.003 | 1.70 (0.89–3.23) | 0.11 | 1.85 (1.29–2.66) | 0.001 | 1.41 (0.91–2.18) | 0.13 |
DA 5 | 2.60 (1.42–4.76) | 0.002 | 1.54 (0.77–3.10) | 0.22 | 2.25 (1.57–3.22) | < 0.001 | 2.13 (1.40–3.23) | < 0.001 |
Trend DA | 1.28 (1.12–1.46) | < 0.001 | 1.12 (0.96–1.30) | 0.14 | 1.23 (1.14–1.33) | < 0.001 | 1.20 (1.10–1.32) | < 0.001 |
Postmenopausal | 3.00 (1.93–4.67) | < 0.001 | 2.67 (1.60–4.47) | < 0.001 | 0.60 (0.48–0.75) | < 0.001 | 0.63 (0.48–0.83) | 0.001 |
Previous Screening | 0.80 (0.42–1.55) | 0.51 | 1.34 (0.52–3.41) | 0.54 | 0.81 (0.61–1.08) | 0.15 | 0.82 (0.58–1.16) | 0.26 |